Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

J147

Other · developed by Abrexa Pharmaceuticals

Phase 2 Most advanced trial
1 Registered trials

What is J147?

J147 is an investigational drug studied in Acute Ischemic Stroke.

At a glance

Drug type
Other
Therapy area
Neurology
Developer
Abrexa Pharmaceuticals, Inc.
In trials of
IQV
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2
UNII
Z41H3C5BT9

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07430917 Phase 2 Acute Ischemic Stroke Recruiting IQV

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acute Ischemic Stroke

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.